
Photo by Innerbody Research
You might be surprised to know how many people live with chronic pain, systemic inflammation, daily stress, or cognitive disability. It’s something like 7-49% of Americans, according to some sources.1 2 3 58 And if you’re among them, you probably know well the struggle of finding nonprescription relief.
But a cannabis-derived compound called cannabigerol (CBG) may be able to help.
In this guide to the best CBG gummies, we discuss the current research on CBG and the qualities of our top four picks on the market. By the end, you ought to have all the information you need to choose the right option for your health needs.
For the quick version, check out our summary of recommendations below. Then read further to understand how we arrived at our conclusions.
This gummy contains a potent amount of CBG supported by available research, and Neurogan excels in quality assurance with third-party testing for potency and purity.
Though a person’s ideal CBG gummy depends on goals, Neurogan’s potency allows it to align most with the breadth of positive research into CBG’s effects. Whether your goal is anxiety relief, pain relief, or a cognitive boost, Neurogan is uniquely strong enough to help; other products fall short of it in dosage. And thanks to its robust third-party testing, you can confirm it’s a full-spectrum product that delivers an entourage effect without introducing hardly any THC (just a tenth of a mg). While neither the cheapest nor the tastiest, it’s the best CBG gummy of all that we tested.
Over the past two decades, Innerbody Research has helped tens of millions of readers make more informed decisions involving staying healthy and living healthier lifestyles.
In that time, we’ve spent thousands of hours researching, testing, and tasting various cannabinoid products, with a focus on CBD, CBG, and CBN. This guide alone represents more than 70 hours of our work in the area. This clock time includes our investigation of the competitive landscape and interactions with top brands, enabling us to provide you with a ground-level view of the customer experience.
Additionally, like all health-related content on this website, this review was thoroughly vetted by one or more members of our Medical Review Board for accuracy. As the research into CBG and other minor cannabinoids develops, we’ll update this guide accordingly.
To identify the best CBG gummies on the market, we surveyed the landscape and assessed our options based on these criteria:
While all four of our recommendations performed well overall, certain brands stood out in specific categories.
Advantage: Neurogan CBG Gummies
Supplements like CBG gummies aren’t regulated by the FDA in the same way as prescription medications,9 so it’s the manufacturers that are responsible for ensuring consumer safety. Thankfully, the companies behind all of our top picks take the necessary steps to ensure their hemp products are safe: third-party testing and reporting their test results.
Neurogan manages to squeak ahead of the others, though, for two reasons:
Lazarus Naturals, containing just one other well-tolerated cannabinoid, is nearly as safe, except that it contains a little more than 1mg THC per gummy. Is that enough to impair the user? Probably not, but reactions to THC vary by individual, and in terms of pure numbers, its theoretical risk is higher than Neurogan’s.
Hemp Bombs isn’t too bad here, either, but it contains three functional mushrooms. True, mushrooms are not among the nine major allergens, but a small percentage of people may still be allergic to them.10 11 Also, the mushrooms in question can potentially cause gastrointestinal side effects.
Urb comes in last because it’s primarily a delta-9 THC product, so even with its moderate 5mg quantity, it can still get you high enough to slow your coordination, reaction time, decision-making, and executive thinking. A serving of it has an intoxicating effect that the other products here do not.
Advantage: Neurogan CBG Gummies
Assessing effectiveness, we based our pick on the product’s potential to help users realize CBG’s primary benefits: focus and memory, anxiety relief, pain relief, and anti-inflammation. We measured each gummy’s characteristics against the scientific literature, and we ruled out any that contained components that could interfere with its benefits.
We picked Neurogan here because, with respect to these benefits, it covers the most ground, so to speak. That is, while nootropic and anxiolytic effects may kick in at around 20mg,7 you’d do better with something like a 50mg dose to relieve pain and inflammation.64 Neurogan’s 45mg dose is the closest to the 50mg threshold we’ve seen in a reputable brand, and you can easily halve a gummy if you’re seeking strictly an anti-anxiety or cognitive boost.
That being said, if a brain boost is all you want, then our recommendation for you is Hemp Bombs CBD Gummies + Mushrooms, as it has three functional mushrooms — lion’s mane, reishi, and cordyceps — that could potentially promote better cognition.13
Urb and Lazarus Naturals are excellent in their own right, but their 25mg CBG dose is nearly half that of Neurogan. As for Urb, specifically, its higher THC content may offset any nootropic effects, depending on your tolerance level.
Insider Tip: Our testers found that a half-gummy of Urb Boarding Skybites was enough to feel a tingle of a high while remaining mentally functional and productive.
Advantage: Urb Boarding Skybites
Even though Urb doesn’t have a subscription program, its low up-front price, bulk purchasing options, and loyalty program put it ahead of the competition on cost. The table below lays out the head-to-head (prices are rounded to the nearest cent; Lazarus Naturals’ prices relate to the full-size bottle).
| Urb | Hemp Bombs | Lazarus Naturals | Neurogan | |
|---|---|---|---|---|
| One-time $ | $24.99 | $30.00 | $60.00 | $65.00 |
| Subscription $ | N/A | $22.50 | $51.00 | $49.00 |
| Bulk $ per bottle | $21.24-$22.49 | N/A | $48.33 ($41.08 on subscription) | N/A |
| Per-serving $ | $0.71-$0.83 | $0.75-$1.00 | $1.03-$1.50 | $1.63-$2.17 |
| Other discounts | Up to 30% off with loyalty points | Rewards program, as well as 50% off for healthcare workers, firefighters, law enforcement, other public servants, and government officials (including retired personnel) | Rewards program, as well as up to 60% off for veterans, people on long-term disability, and low-income households | Rewards program, as well as discounts for teachers, students, senior citizens, nonprofit workers, people on assistance, healthcare workers, military, first responders, and government officials |
In terms of the lowest-end per-serving cost, Urb is several cents lower than the closest competitor. And if you take our insider tip (halving your Urb gummy for a functional effect), your effective cost is even lower.
Advantage: Lazarus Naturals CBD:CBG Gummies
Among our top picks, customer convenience ultimately came down to two factors:
Lazarus Naturals is the clear winner on both points. Look back at our pricing table from earlier, and you’ll see that Lazarus is the only one that offers both a subscription program and bulk purchasing, in addition to the largest advertised discount for select populations. Then look at Lazarus’ website, and you’ll find the company offers a 90-day satisfaction guarantee with free returns. A lot of thought has gone into making the purchasing decision as gentle as possible for the customer.
Neurogan and Hemp Bombs do all right on both points, too, but their return periods are only 30 days long, and Neurogan accepts only unopened items. Urb, on the other hand, has a no-return policy.
Winner: Lazarus Naturals CBD:CBG
None of our picks has that earthy-grassy taste typical of hemp products. But only one of them can be said to taste good. That’s Lazarus Naturals CBD:CBG (Mixed Berry). Had we not known we were eating a hemp edible, we’d have thought it was a regular ol’ gummy from the candy store.
Neurogan and Urb don’t share that quality:
Hemp Bombs (Blackberry Lemonade) has an okay flavor, but it somehow comes off as artificial. We don’t know how that could be, seeing as it comes from sugar and corn syrup, yet there you have it. Hemp Bombs also has a stiffer chew than Lazarus, evoking the lower-quality, bargain-bin candies one might find at the dollar store.
The chart below offers a quick breakdown of how our top four CBG gummy picks compare in key areas. (The table does not reflect bulk purchasing options. For Lazarus Naturals, we used the full-size bottle as the reference.)
| Neurogan | Lazarus Naturals | Urb | Hemp Bombs | |
|---|---|---|---|---|
| CBG content per serving | 45mg | 25mg | 25mg | 15mg |
| Additional cannabinoids | N/A | 25mg CBD | 25mg CBD, 10mg CBC, 5mg delta-9 THC | 15mg CBD |
| Other notable ingredients | N/A | N/A | N/A | 500mg lion’s mane, 250mg cordyceps, 250mg reishi |
| Servings per container | 30 | 40 | 30 | 30 |
| One-time purchase price | $65.00 | $60.00 | $24.99 | $30.00 |
| One-time cost per serving | $2.17 | $1.50 | $0.83 | $1.00 |
| Subscription price | $49.00 | $51.00 | N/A | $22.50 |
| Subscription cost per serving | $1.63 | $1.28 | N/A | $0.75 |
| Refund policy | 30-day window, unopened | 90-day guarantee | No refunds | 30-day guarantee |
| Flavor | Watermelon | Mixed Berry | Mixed Berry | Blackberry Lemonade |
| Third-party tested? |
CBG refers to cannabigerol, one of the 150+ biologically active compounds in the Cannabis sativa plant known as cannabinoids. The precursor to CBG, cannabigerolic acid (CBGA), is the “parent compound” to tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabichromene (CBC), which is why you may see CBG described as the “mother of all cannabinoids.”14 15 Even so, CBG is considered a “minor” cannabinoid since it’s present in smaller quantities than the “major” players, THC and CBD.
CBG is nonpsychoactive, so it won’t get you high, and recreational use isn’t its primary selling point.16 Rather, the main reasons why people take CBG relate to its effects on:
We cover CBG’s benefits in these and other areas under “How does CBG work?”
At the time of this writing, CBG remains legal to purchase and use in the United States as long as it’s derived from hemp and contains less than 0.3% delta-9-THC on a dry weight basis.17
But there are two caveats to consider:
The new “hemp ban” takes effect in November 2026. In the meantime, some states and political leaders are trying to loosen the strictures of the prohibition, and existing state-level laws may continue to protect full-spectrum products within state borders. We’ll be following these and related changes as they unfold and update this guide accordingly.
Cannabinoids (like CBG) are the biologically active compounds derived from the Cannabis sativa plant. They affect certain receptors that make up the endocannabinoid system (ECS) and help to control a wide range of the body’s day-to-day functions (e.g., hunger, temperature, pain).25
There are two types of ECS receptors:26 27
While CBG binds to both receptors, it prefers CB2 (mainly in the body) over CB1 (mainly in the brain and nervous system).29 30 That’s why it doesn’t produce a psychoactive effect. In contrast, THC has a very high binding affinity for CB1 receptors, which is why it does cause psychoactive effects.31
CBG’s higher affinity for CB2 receptors could explain why several of its potential benefits involve the body’s immune system, GI system, and peripheral tissues.
Most studies on CBG have been conducted on animal models or cell cultures. High-quality human studies are scarce, and much more research is needed. Still, the existing research is favorable to CBG across a broad range of potential benefits.16
Below is the most promising research behind CBG’s most common therapeutic uses:
A few studies suggest that CBG provides nootropic and neuroprotective benefits to some degree. For example, in 2024, mice that received 25-100mg/kg doses demonstrated improvements in spatial short-term memory, and a comprehensive review from the same year found that CBG could reduce neurodegenerative biomarkers in rats.59 60 More recently, a 2025 mouse study found that CBG “attenuated ischemia-induced memory deficits, reduced neuronal loss in the hippocampus, and enhanced neuronal plasticity.”61
Human studies have yielded similar results, with a 2024 trial showing “enhanced verbal memory relative to placebo” with a 20mg dose.7
In the same 2024 trial, in which 34 healthy adult participants were given either 20mg of CBG or a placebo, researchers found a “significant” effect from CBG versus placebo on overall reductions in feelings of anxiety and stress.7
In a 2022 study, researchers reported that CBG inhibits certain inflammatory enzymes better than “conventional anti-inflammatory compounds.”6 This ability may explain why CBG appears to reduce intestinal inflammation in rodents with colitis.32 (CBG’s effect on inflammation also reinforces the notion that it has neuroprotective properties.)33
Additionally, a review from 2008 noted that CBG could potentially be used as a muscle relaxant, seemingly performing better than THC at reducing pain, redness, and the activity of certain inflammatory enzymes.5
Apart from the benefits we’ve discussed, CBG has been found to have additional uses for multiple health concerns that most consumers may not be aware of. These include:
In a 2008 study, CBG, along with other cannabinoids, was shown to have “potent activity” against various treatment-resistant strains of Staphylococcus aureus (i.e., methicillin-resistant Staphylococcus aureus, or MRSA).23 With nearly 20,000 MRSA-associated deaths occurring during 2017 in the United States alone, CBG looks like it could be a handy treatment for a common infection.34
A 2016 study on rats found that CBG can greatly increase hunger, leading subjects to more than double their food consumption. The researchers thus noted that CBG could benefit people with cachexia (wasting syndrome) or other health conditions that require body weight regulation.8
CBG may inhibit certain types of cancer, according to a few studies. In one review, the authors found that CBG appeared to “reduce the survival of glioblastoma cells,” similar to the chemotherapy drug temozolomide,19 and a separate study determined that CBG could “inhibit the invasion of glioblastoma cells” and destroy therapy-resistant ones.22
Similar inhibitory effects have been observed in colorectal cancer, as in a 2024 cell study that found that CBG inhibited cancer growth by “inducing apoptosis” (natural cell death) and preventing the formation of new, tumor-supporting blood vessels.20 In addition, a 2014 study using a mouse model of colon cancer found that CBG inhibited tumor growth and prevented healthy cells from becoming cancerous.21
CBG should be generally safe for healthy, nonpregnant, non-breastfeeding adults aged 25 or older (certain parts of the brain don’t reach full maturity until age 25, and cannabis products might have long-term cognitive effects on people who are younger).18 57 It’s metabolized in the liver, so the main safety concern relates to hepatotoxicity, but a 2025 in vitro study found that CBG yielded “unchanged liver injury markers,” and a 2023 human trial with 100mg CBG/day reported no serious adverse events.62 63 64 No CBG gummies that we’ve found come close to delivering 100mg per dose.
There are, however, some less-severe safety concerns to be aware of:
As long as you don’t meet the exclusion criteria, you might consider adding CBG to your health regimen if you regularly experience:
To a lesser degree, CBG supplementation could be a low-risk preventive measure for MRSA infection and certain cancers.23 19 20
But with all that being said, CBG has its limits. It’s unlikely to make a meaningful difference in instances of, say, complex regional pain, age-related cognitive decline, or clinical anxiety — you’d do better to seek a prescription-strength solution instead. Similarly, you shouldn’t expect CBG to armor-plate you against infections and cancers in general; notwithstanding genetic factors, you should focus foremost on lifestyle modifications that keep you from developing these conditions in the first place.
And we’d be remiss not to mention that certain CBG products may be off the table altogether if you live in a state with heavy restrictions on hemp products. Current examples of such states include Idaho, Oregon, California, and Rhode Island, but this list is far from exhaustive and may grow or shrink over time. Please consult your state’s hemp laws to determine whether you have access to the products we recommend.
Best CBG-only gummy

Photo by Innerbody Research
Previously, the market seemed to lack a CBG gummy from a reputable brand with a dose high enough to cover all of CBG’s potential benefits. Neurogan CBG gummies fill that void. Its 45mg/serving dose is nearly twice as much as needed to relieve stress and anxiety, while being right on the cusp of the amount shown to be effective for pain and inflammation.7 64
Full-spectrum CBG is Neurogan’s only active ingredient. Bear in mind that being CBG-only isn’t the same as being a CBG isolate. Hemp products made with isolates contain exclusively those cannabinoids, with no traces of THC or other compounds. Neurogan, however, is a full-spectrum product, so it has trace amounts of other cannabinoids, including THC.35 But the THC content here is so minimal (around a tenth of a milligram per serving) that it’s extremely unlikely to intoxicate you at all.
At the same time, the additional cannabinoids in such a full-spectrum extract have the potential to produce the “entourage effect,” which refers to a theoretical synergy between the multiple compounds that may provide better outcomes.36 So, with Neurogan, you have the chance of enhanced calming and relief effects with little risk of incapacitation (e.g., the loss of coordination or transient paranoia associated with THC).37
Taste-wise, Neurogan is just all right. It doesn’t taste awful, but it kind of comes off as though it’s trying to hide a medicinal flavor. It has a peculiar smell, too, not unlike a sterile gauze pad.
Neurogan’s price is a drawback:
At the one-time-purchase level, it’s the most expensive product we recommend in this guide. And the return policy is the worst, as only unopened products qualify for a refund within 30 days.
Neurogan does, however, have a broad discount program for teachers, students, senior citizens, nonprofit workers, people on assistance, healthcare workers, military members, first responders, and government officials (percentage unspecified). There’s also a rewards program that nets you a free CBD product every time you level up, as well as 3-7% back on all purchases at various reward levels.
Best budget CBG gummy, best with THC

Photo by Innerbody Research
Urb is first and foremost a delta-9 THC brand, but its Boarding Skybites gummies deliver less THC than most of its catalog. At just 5mg per gummy, it’s enough to get you feeling nice without totally incapacitating you. In testing, most of us were able to maintain a strong focus on our tasks even with a full serving. Only one of us felt they needed to halve the serving to keep from feeling unproductive.
Urb’s inclusion of cannabichromene (CBC) may also be a good choice for people experiencing inflammation. CBC has anti-inflammatory effects similar to CBG.6 Several animal studies have shown that CBC can reduce inflammation and edema in mice and rats, and it may be beneficial for conditions like inflammatory bowel disease and rheumatoid arthritis.12
On the taste front, though, the Boarding Skybites are disappointing. For some reason, they taste faintly of Robitussin, the cough syrup. No idea why that should be, especially since most of Urb’s products taste pretty good.
Urb doesn’t have a subscription program, but it does have a low price point, as well as bulk purchasing options:
Its base is already lower than the one-time purchase price of any other recommendation in this guide, and its lowest per-serving cost is several cents less than Hemp Bombs.
Also, you can see further savings if you sign up for the Urb Miles loyalty program. Every dollar you spend gets you 5-20 Urb Miles, depending on your level. After 3,750 Urb Miles, you unlock free shipping; at 1,250-7,500 Urb Miles, it’s $5-$30 off your order; and thereafter you can get up to 30% off your order.
Returns, however, are not an option.
Best CBG and CBD combination, best-tasting CBG gummies

Photo by Innerbody Research
Lazarus Naturals CBD:CBG Gummies contain 25mg each of the cannabinoids in its name. The 25mg of CBD is the same as in Urb, but Lazarus stands apart for having only trace amounts of THC. It’s our recommendation to anyone who wants the CBD without the THC high.
We’ve covered that 25mg of CBG is sufficient for focus, memory, anxiety, and stress, but we haven’t yet touched on the complementary effects of CBD. In short, at 25mg, it too ought to provide some anxiety relief, as well as a small degree of pain relief.65 66 Most successful CBD pain studies have used larger doses, however, so you shouldn’t expect much in the way of analgesia
Where Lazarus Naturals does not fall short is in flavor. If we didn’t know that we were testing CBG gummies, we’d have thought Lazarus Naturals came straight from the candy store. It’s chewy and fruity, almost like a Gushers without the gush, and sweet without being cloying. Our testers liked eating it more than any other product in this guide.
Alongside Urb, Lazarus Naturals is the only other one of our recommendations that offers bulk purchasing in addition to a one-time purchase. But unlike Urb, Lazarus has a subscription option, too, along with a lower-cost ten-count sample pack. This table breaks it all down:
| 10ct | 40ct | |
|---|---|---|
| One-time purchase | $16.00 ($1.60 per serving) | $60.00 ($1.50 per serving) |
| Subscription | $13.60 ($1.36 per serving) | $51.00 ($1.28 per serving) |
| One-time bulk (6 units) | N/A | $290.00 ($48.33 per bottle, $1.21 per serving) |
| Subscription bulk (6 units) | N/A | $246.50 ($41.08 per bottle, $1.03 per serving) |
The cost is still high enough that Lazarus Naturals is the second-most expensive option we recommend, but you can see that it gets significantly lower than Neurogan. Also, Lazarus has a 90-day money-back guarantee, which absolutely beats Neurogan’s 30-day non-guarantee.
In addition, Lazarus Naturals has a generous discount program that subtracts 60% for veterans, people on long-term disability, and low-income households. Moreover, like our other recs, it has a rewards program, which gives you a $5-$40 discount depending on how many points you accumulate.
Best CBG gummy with additional focus-boosting ingredients

Photo by Innerbody Research
Hemp Bombs Focus CBD Gummies are (as the name suggests) intended to support better focus. Each gumdrop-like gummy contains:
While the CBD and CBG content is important, the addition of the three functional mushrooms is what distinguishes Focus as a cognitive booster:38
So, although more studies are needed, especially in humans, the current research on both mushrooms and CBG suggests that Hemp Bombs Focus Gummies are well-formulated to help improve memory and motivation.
Our testing generally corroborates the implications of the existing literature, although our “energy boost” wasn’t anything major (possibly owing to the relatively low CBG dose). That’s not necessarily a bad thing. It means we didn’t have to reshape our caffeine regimens around the supplement; it was just another helpful thing we consumed alongside our morning coffees.
As a one-time purchase, a bottle of Hemp Bombs Focus Gummies is $30 ($1.00 per serving), a drop of $5 since the last time we looked in on them. A subscription knocks off 25%, bringing the price to $22.50 ($0.75 per serving).
Further savings are available through Hemp Bombs’ discount program. If you belong to any of the following groups, you’re eligible for a whopping 50% lifetime discount:
The discount reduces the price of a single bottle to just $15 or $11.25, depending on your mode of purchase.
With Hemp Bombs’ rewards program, you can see even more savings: up to 30% off, depending on how many points you have.
Hemp Bombs also has a customer-friendly money-back guarantee. The return window is just 30 days, but it’s a no-questions-asked policy, free of any fine-print caveats, except for suspected illegitimate requests. It applies to all items purchased through the official website.
Depending on your needs, CBG gummies are just one of many products on the market that could potentially help you. In this section, we quickly cover a few alternatives.
If you’re intrigued by the mushroom content in Hemp Bombs, then you might consider mushroom coffee instead. They’re typically drink powders (with or without actual coffee in them) consisting of multiple functional mushrooms for enhanced cognition and stress relief,43 42 and some that may even improve how tumors respond to certain chemotherapies.44
To learn more about mushroom coffee, check out our guide to the best options.
Several common botanical supplements may serve as excellent substitutes for CGB’s anxiolytic and anti-inflammatory properties. Our favorites include:
And if you’re looking for a nootropic supplement that includes smart doses of all four of these, consider Focus Support by Innerbody Labs. It also contains the equivalent of 2g of lion’s mane mushroom fruiting body.
Other cannabinoids can also take the place of CBG in your supplement rotation. A CBN gummy would be a good choice, as studies have shown that it can potentially improve sleep,52 relieve pain,53 and reduce inflammation.54
CBD is another good one, and one that’s much more widely available. Like CBG, it can reduce stress, anxiety, and pain while also promoting better sleep.55 56
Sources
Innerbody uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
Lucas, J. W., & Sohi, I. (2023). Chronic pain and high-impact chronic pain in U.S. adults, 2023. CDC.
Sharma, P., & Jo, A. (2024). Systemic inflammation among adults with diagnosed and undiagnosed cardiometabolic conditions: A potential missed opportunity for cardiovascular disease prevention. Frontiers in Medicine, 10, 1327205.
The American Institute of Stress. (2025). What the latest reports say about stress in America. AIS.
Maioli, C., Mattoteia, D., M Amin, H. I., Minassi, A., & Caprioglio, D. (2022). Cannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid. Plants, 11(21), 2896.
Russo, E. B. (2008). Cannabinoids in the management of difficult to treat pain. Therapeutics and Clinical Risk Management, 4(1), 245.
Calapai, F., Cardia, L., Esposito, E., Ammendolia, I., Mondello, C., Giudice, R. L., Gangemi, S., Calapai, G., & Mannucci, C. (2022). Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives. Evidence-Based Complementary and Alternative Medicine: ECAM, 2022, 3336516.
Cuttler, C., Stueber, A., Cooper, Z. D., & Russo, E. (2024). Acute effects of cannabigerol on anxiety, stress, and mood: A double-blind, placebo-condotrolled, crossover, field trial. Scientific Reports, 14(1), 1-14.
Brierley, D. I., Samuels, J., Duncan, M., Whalley, B. J., & Williams, C. M. (2016). Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats. Psychopharmacology, 233(19), 3603.
U.S. Food and Drug Administration. (2022). FDA 101: Dietary Supplements. FDA.
U.S. Food and Drug Administration. (2024). Food Allergies: What You Need to Know. FDA.
Anusiya, G., Prabu, U. G., Yamini, N. V., Sivarajasekar, N., Rambabu, K., Bharath, G., & Banat, F. (2021). A review of the therapeutic and biological effects of edible and wild mushrooms. Bioengineered, 12(2), 11239.
Sepulveda, D. E., Vrana, K. E., Kellogg, J. J., Bisanz, J. E., Desai, D., Graziane, N. M., & Raup-Konsavage, W. M. (2024). The Potential of Cannabichromene (CBC) as a Therapeutic Agent. The Journal of Pharmacology and Experimental Therapeutics, 391(2), 206.
Nkodo, A. (2019). A Systematic Review of in-vivo Studies on Dietary Mushroom Supplementation for Cognitive Impairment (P14-021-19). Current Developments in Nutrition, 3(Suppl 1), nzz052.P14-021-19.
Russo, E. B. (2016). Beyond Cannabis: Plants and the Endocannabinoid System. Trends in Pharmacological Sciences, 37(7), 594-605.
Russo, E. B., Cuttler, C., Cooper, Z. D., Stueber, A., Whiteley, V. L., & Sexton, M. (2022). Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms. Cannabis and Cannabinoid Research, 7(5), 706.
Grinspoon, P. (2022). Beyond CBD: Here come the other cannabinoids, but where’s the evidence? Harvard Health Publishing.
U.S. Food and Drug Administration. (2024). FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD). FDA.
Gottschling, S., Ayonrinde, O., Bhaskar, A., Blockman, M., Schecter, D., Suárez Rodríguez, L. D., Yafai, S., & Cyr, C. (2020). Safety Considerations in Cannabinoid-Based Medicine. International Journal of General Medicine, 13, 1317.
Jastrząb, A., & Skrzydlewska, E. (2022). The Origin and Biomedical Relevance of Cannabigerol. International Journal of Molecular Sciences, 23(14), 7929.
Bęben, D., Siwiela, O., Szyjka, A., Graczyk, M., Rzepka, D., Barg, E., & Moreira, H. (2024). Phytocannabinoids CBD, CBG, and their Derivatives CBD-HQ and CBG-A Induced In Vitro Cytotoxicity in 2D and 3D Colon Cancer Cell Models. Current Issues in Molecular Biology, 46(4), 3626.
Borrelli, F., Pagano, E., Romano, B., Panzera, S., Maiello, F., Coppola, D., De Petrocellis, L., Buono, L., Orlando, P., & Izzo, A. A. (2014). Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid. Carcinogenesis, 35(12), 2787-2797.
Lah, T. T., Novak, M., Pena Almidon, M. A., Marinelli, O., Baškovič, B. Ž., Majc, B., Mlinar, M., Bošnjak, R., Breznik, B., Zomer, R., & Nabissi, M. (2021). Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma. Cells, 10(2), 340.
Appendino, G., Gibbons, S., Giana, A., Pagani, A., Grassi, G., Stavri, M., Smith, E., & Rahman, M. M. (2008). Antibacterial cannabinoids from Cannabis sativa: a structure-activity study. Journal of Natural Products, 71(8), 1427-1430.
Mangot, A. G. (2013). Bad trip due to anticholinergic effect of cannabis. General Hospital Psychiatry, 35(6), 682.e5-682.e6.
Grinspoon, P. (2021). The endocannabinoid system: Essential and mysterious. Harvard Health Publishing.
Atakan, Z. (2012). Cannabis, a complex plant: Different compounds and different effects on individuals. Therapeutic Advances in Psychopharmacology.
Zou, S., & Kumar, U. (2018). Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. International Journal of Molecular Sciences, 19(3), 833.
Bie, B., Wu, J., Foss, J. F., & Naguib, M. (2018). An overview of the cannabinoid type 2 (CB2) receptor system and its therapeutic potential. Current Opinion in Anaesthesiology, 31(4), 407.
Richter, G., Hazzah, T., Hartsel, J. A., Eades, J., Hickory, B., & Makriyannis, A. (2021). Cannabis sativa: An overview. Nutraceuticals (Second Edition), 603-624.
Hazekamp, A., Fischedick, J. T., Díez, M. L., Lubbe, A., & Ruhaak, R. L. (2010). Chemistry of Cannabis. Comprehensive Natural Products II, 1033-1084.
Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. (2018). Cannabinoids and Pain: New Insights From Old Molecules. Frontiers in Pharmacology, 9, 416167.
Couch, D. G., Maudslay, H., Doleman, B., Lund, J. N., & E, S. (2018). The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases, 24(4), 680-697.
Gugliandolo, A., Pollastro, F., Grassi, G., Bramanti, P., & Mazzon, E. (2018). In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid. International Journal of Molecular Sciences, 19(7), 1992.
Centers for Disease Control and Prevention. (2019). Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States. CDC.
Cather, J. C., & Cather, J. C. (2020). Cannabidiol primer for healthcare professionals. Proceedings (Baylor University. Medical Center), 33(3), 376.
Ferber, S. G., Namdar, D., Hen-Shoval, D., Eger, G., Koltai, H., Shoval, G., Shbiro, L., & Weller, A. (2020). The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders. Current Neuropharmacology, 18(2), 87.
Freeman, D., Dunn, G., Murray, R. M., Evans, N., Lister, R., Antley, A., Slater, M., Godlewska, B., Cornish, R., Williams, J., Simplicio, M. D., Igoumenou, A., Brenneisen, R., Tunbridge, E. M., Harrison, P. J., Harmer, C. J., Cowen, P., & Morrison, P. D. (2014). How Cannabis Causes Paranoia: Using the Intravenous Administration of ∆9-Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia. Schizophrenia Bulletin, 41(2), 391.
Venturella, G., Ferraro, V., Cirlincione, F., & Gargano, M. L. (2021). Medicinal Mushrooms: Bioactive Compounds, Use, and Clinical Trials. International Journal of Molecular Sciences, 22(2), 634.
Yuan, G., An, L., Sun, Y., Xu, G., & Du, P. (2018). Improvement of Learning and Memory Induced by Cordyceps Polypeptide Treatment and the Underlying Mechanism. Evidence-Based Complementary and Alternative Medicine: ECAM, 2018, 9419264.
Docherty, S., Doughty, F. L., & Smith, E. F. (2023). The Acute and Chronic Effects of Lion’s Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. Nutrients, 15(22), 4842.
Khatian, N., & Aslam, M. (2019). Effect of Ganoderma lucidum on memory and learning in mice. Clinical Phytoscience, 5(1), 1-8.
Giridharan, V. V., Thandavarayan, R. A., & Konishi, T. (2011). Amelioration of scopolamine induced cognitive dysfunction and oxidative stress by Inonotus obliquus - a medicinal mushroom. Food & Function, 2(6), 320-327.
Nagano, M., Shimizu, K., Kondo, R., Hayashi, C., Sato, D., Kitagawa, K., & Ohnuki, K. (2010). Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical Research (Tokyo, Japan), 31(4), 231-237.
Jin, X., Beguerie, J. R., & Chan, G. C. (2016). Ganoderma lucidum (Reishi mushroom) for cancer treatment. The Cochrane Database of Systematic Reviews, 2016(4), CD007731.
National Institutes of Health. (2024). Ashwagandha: Is it helpful for stress, anxiety, or sleep? NIH.
Evans, M., et al. (2021). A randomized, triple-blind, placebo-controlled, crossover study to investigate the efficacy of a single dose of AlphaWave® L-theanine on stress in a healthy adult population. Neurology and Therapy, 10, 1061-1078.
Hidese, S., et al. (2019). Effects of L-theanine administration on stress-related symptoms and cognitive functions in healthy adults: A randomized controlled trial. Nutrients, 11(10), 2362.
Jackson, P. A., et al. (2021). Effects of Saffron extract supplementation on mood, well-being, and response to a psychosocial stressor in healthy adults: A randomized, double-blind, parallel group, clinical trial. Frontiers in Nutrition, 7, 606124.
Zeinali, M., Zirak, M. R., Rezaee, S. A., Karimi, G., & Hosseinzadeh, H. (2019). Immunoregulatory and anti-inflammatory properties of Crocus sativus (Saffron) and its main active constituents: A review. Iranian Journal of Basic Medical Sciences, 22(4), 334.
Khazdair, M. R., Boskabady, M. H., Hosseini, M., Rezaee, R., & Tsatsakis, A. M. (2015). The effects of Crocus sativus (saffron) and its constituents on nervous system: A review. Avicenna Journal of Phytomedicine, 5(5), 376.
Stojcheva, E. I., & Quintela, J. C. (2022). The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions—Encouraging Clinical Evidence. Molecules, 27(12), 3902.
Bonn-Miller, M. O., Feldner, M. T., Bynion, T. M., Eglit, G. M. L., Brunstetter, M., Kalaba, M., Zvorsky, I., Peters, E. N., & Hennesy, M. (2024). A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality. Experimental and Clinical Psychopharmacology, 32(3), 277-284.
Wong, H., & Cairns, B. E. (2019). Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain. Archives of Oral Biology, 104, 33-39.
Khouchlaa, A., Khouri, S., Hajib, A., Zeouk, I., Amalich, S., Msairi, S., El Menyiy, N., Rais, C., Lahyaoui, M., Khalid, A., Abdalla, A. N., Ibrahim, S. E., El Omari, N., Goh, B. H., Kumari, Y., Tan, S. L., & Bouyahya, A. (2024). Health benefits, pharmacological properties, and metabolism of cannabinol: A comprehensive review. Industrial Crops and Products, 213, 118359.
Moltke, J. & Hindocha, C. (2021). Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems. Journal of Cannabis Research, 3, 5.
Capano, A., Weaver, R., & Burkman, E. (2020). Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study. Postgraduate Medicine, 132(1), 56-61.
Arain, M., Haque, M., Johal, L., Mathur, P., Nel, W., Rais, A., Sandhu, R., & Sharma, S. (2013). Maturation of the adolescent brain. Neuropsychiatric Disease and Treatment, 9, 449.
Saey, T. H. (2025). More young U.S. adults report trouble with memory and focus. ScienceNews.
Carone, M., et al. (2024). Behavioral effects of two cannabidiol and cannabigerol-rich formulas on mice. Heliyon, 10(21), e39938.
Li, S., et al. (2024). Cannabigerol (CBG): A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules, 29(22).
Neves Kohara, N. A., et al. (2025). Cannabigerol attenuates memory impairments, neurodegeneration, and neuroinflammation caused by transient global cerebral ischemia in mice. International Journal of Molecular Sciences, 26(16).
Calapai, F., et al. (2022). Pharmacological aspects and biological effects of cannabigerol and its synthetic derivatives. Evidence-Based Complementary and Alternative Medicine, 2022(1), 3336516.
Larson, J. D., et al. (2025). Hepatotoxicity evaluation of cannabidiol, cannabinol, cannabichromene and cannabigerol using a human quad culture liver chip. Scientific Reports, 15(1), 28132.
Peters, E. N., et al. (2025). A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS). Journal of the International Society of Sports Nutrition, 20(1).
Skelley, J. W., et al. (2020). Use of cannabidiol in anxiety and anxiety-related disorders. Journal of the American Pharmacists Association, 60(1), 253-261.
Cásedas, G., & López, V. (2024). Cannabidiol (CBD): A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals, 17(11).